ClinVar Miner

Submissions for variant NM_001849.4(COL6A2):c.2592G>A (p.Thr864=)

gnomAD frequency: 0.01149  dbSNP: rs1042930
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 9
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Eurofins Ntd Llc (ga) RCV000116793 SCV000202543 benign not specified 2013-12-17 criteria provided, single submitter clinical testing
PreventionGenetics, part of Exact Sciences RCV000116793 SCV000308299 benign not specified criteria provided, single submitter clinical testing
Illumina Laboratory Services, Illumina RCV000290550 SCV000436786 likely benign Myosclerosis 2016-06-14 criteria provided, single submitter clinical testing
Illumina Laboratory Services, Illumina RCV000347826 SCV000436787 likely benign Collagen 6-related myopathy 2016-06-14 criteria provided, single submitter clinical testing
Illumina Laboratory Services, Illumina RCV000352852 SCV000483960 likely benign Glutamate formiminotransferase deficiency 2016-06-14 criteria provided, single submitter clinical testing
Labcorp Genetics (formerly Invitae), Labcorp RCV000554539 SCV000657156 benign Bethlem myopathy 1A 2025-01-29 criteria provided, single submitter clinical testing
GeneDx RCV000116793 SCV000713887 benign not specified 2017-02-13 criteria provided, single submitter clinical testing This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.
Breakthrough Genomics, Breakthrough Genomics RCV004703381 SCV005207703 likely benign not provided criteria provided, single submitter not provided
Genetic Services Laboratory, University of Chicago RCV000116793 SCV000150813 likely benign not specified no assertion criteria provided clinical testing Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.